Global Tumor Embolization Market Research Report 2022

Report Format: PDF   |   Report ID: 5515635   |   Published Date: August 2022   |   Pages:  67  

Choose License
Market Analysis and Insights: Global Tumor Embolization Market
The global Tumor Embolization market size is projected to reach US$  million by 2028, from US$  million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Trans-Arterial Embolization (TAE) accounting for % of the Tumor Embolization global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Tumor Embolization market size is valued at US$  million in 2021, while the North America and Europe Tumor Embolization are US$  million and US$  million, severally. The proportion of the North America is  % in 2021, while China and Europe are  % and respectively, and it is predicted that China proportion will reach  % in 2028, trailing a CAGR of  % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR  %,  %, and   % respectively for the next 6-year period. As for the Europe Tumor Embolization landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tumor Embolization market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tumor Embolization market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tumor Embolization market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tumor Embolization market.
Global Tumor Embolization Scope and Market Size
Tumor Embolization market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Tumor Embolization market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Trans-Arterial Embolization (TAE)
    Drug-Eluting Bead Chemoembolization (DEB-TACE)
    Radioembolization (RE)
    Others
Segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Specialty Clinics
    Others
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Boston Scientific Corporation
    Varian Medical Systems, Inc.
    Nordion (Sotera Health)
    Sirtex Medical
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Tumor Embolization Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Trans-Arterial Embolization (TAE)
        1.2.3 Drug-Eluting Bead Chemoembolization (DEB-TACE)
        1.2.4 Radioembolization (RE)
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Tumor Embolization Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Specialty Clinics
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Tumor Embolization Market Perspective (2017-2028)
    2.2 Tumor Embolization Growth Trends by Region
        2.2.1 Tumor Embolization Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Tumor Embolization Historic Market Size by Region (2017-2022)
        2.2.3 Tumor Embolization Forecasted Market Size by Region (2023-2028)
    2.3 Tumor Embolization Market Dynamics
        2.3.1 Tumor Embolization Industry Trends
        2.3.2 Tumor Embolization Market Drivers
        2.3.3 Tumor Embolization Market Challenges
        2.3.4 Tumor Embolization Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Tumor Embolization Players by Revenue
        3.1.1 Global Top Tumor Embolization Players by Revenue (2017-2022)
        3.1.2 Global Tumor Embolization Revenue Market Share by Players (2017-2022)
    3.2 Global Tumor Embolization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Tumor Embolization Revenue
    3.4 Global Tumor Embolization Market Concentration Ratio
        3.4.1 Global Tumor Embolization Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Tumor Embolization Revenue in 2021
    3.5 Tumor Embolization Key Players Head office and Area Served
    3.6 Key Players Tumor Embolization Product Solution and Service
    3.7 Date of Enter into Tumor Embolization Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Embolization Breakdown Data by Type
    4.1 Global Tumor Embolization Historic Market Size by Type (2017-2022)
    4.2 Global Tumor Embolization Forecasted Market Size by Type (2023-2028)
5 Tumor Embolization Breakdown Data by Application
    5.1 Global Tumor Embolization Historic Market Size by Application (2017-2022)
    5.2 Global Tumor Embolization Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Tumor Embolization Market Size (2017-2028)
    6.2 North America Tumor Embolization Market Size by Country (2017-2022)
    6.3 North America Tumor Embolization Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Tumor Embolization Market Size (2017-2028)
    7.2 Europe Tumor Embolization Market Size by Country (2017-2022)
    7.3 Europe Tumor Embolization Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Tumor Embolization Market Size (2017-2028)
    8.2 Asia-Pacific Tumor Embolization Market Size by Country (2017-2022)
    8.3 Asia-Pacific Tumor Embolization Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Tumor Embolization Market Size (2017-2028)
    9.2 Latin America Tumor Embolization Market Size by Country (2017-2022)
    9.3 Latin America Tumor Embolization Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Tumor Embolization Market Size (2017-2028)
    10.2 Middle East & Africa Tumor Embolization Market Size by Country (2017-2022)
    10.3 Middle East & Africa Tumor Embolization Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Boston Scientific Corporation
        11.1.1 Boston Scientific Corporation Company Detail
        11.1.2 Boston Scientific Corporation Business Overview
        11.1.3 Boston Scientific Corporation Tumor Embolization Introduction
        11.1.4 Boston Scientific Corporation Revenue in Tumor Embolization Business (2017-2022)
        11.1.5 Boston Scientific Corporation Recent Development
    11.2 Varian Medical Systems, Inc.
        11.2.1 Varian Medical Systems, Inc. Company Detail
        11.2.2 Varian Medical Systems, Inc. Business Overview
        11.2.3 Varian Medical Systems, Inc. Tumor Embolization Introduction
        11.2.4 Varian Medical Systems, Inc. Revenue in Tumor Embolization Business (2017-2022)
        11.2.5 Varian Medical Systems, Inc. Recent Development
    11.3 Nordion (Sotera Health)
        11.3.1 Nordion (Sotera Health) Company Detail
        11.3.2 Nordion (Sotera Health) Business Overview
        11.3.3 Nordion (Sotera Health) Tumor Embolization Introduction
        11.3.4 Nordion (Sotera Health) Revenue in Tumor Embolization Business (2017-2022)
        11.3.5 Nordion (Sotera Health) Recent Development
    11.4 Sirtex Medical
        11.4.1 Sirtex Medical Company Detail
        11.4.2 Sirtex Medical Business Overview
        11.4.3 Sirtex Medical Tumor Embolization Introduction
        11.4.4 Sirtex Medical Revenue in Tumor Embolization Business (2017-2022)
        11.4.5 Sirtex Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Tumor Embolization Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Trans-Arterial Embolization (TAE) Table 3. Key Players of Drug-Eluting Bead Chemoembolization (DEB-TACE) Table 4. Key Players of Radioembolization (RE) Table 5. Key Players of Others Table 6. Global Tumor Embolization Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Tumor Embolization Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Tumor Embolization Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Tumor Embolization Market Share by Region (2017-2022) Table 10. Global Tumor Embolization Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Tumor Embolization Market Share by Region (2023-2028) Table 12. Tumor Embolization Market Trends Table 13. Tumor Embolization Market Drivers Table 14. Tumor Embolization Market Challenges Table 15. Tumor Embolization Market Restraints Table 16. Global Tumor Embolization Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Tumor Embolization Market Share by Players (2017-2022) Table 18. Global Top Tumor Embolization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Embolization as of 2021) Table 19. Ranking of Global Top Tumor Embolization Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Tumor Embolization Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Tumor Embolization Product Solution and Service Table 23. Date of Enter into Tumor Embolization Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Tumor Embolization Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Tumor Embolization Revenue Market Share by Type (2017-2022) Table 27. Global Tumor Embolization Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Tumor Embolization Revenue Market Share by Type (2023-2028) Table 29. Global Tumor Embolization Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Tumor Embolization Revenue Market Share by Application (2017-2022) Table 31. Global Tumor Embolization Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Tumor Embolization Revenue Market Share by Application (2023-2028) Table 33. North America Tumor Embolization Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Tumor Embolization Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Tumor Embolization Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Tumor Embolization Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Tumor Embolization Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Tumor Embolization Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Tumor Embolization Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Tumor Embolization Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Tumor Embolization Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Tumor Embolization Market Size by Country (2023-2028) & (US$ Million) Table 43. Boston Scientific Corporation Company Detail Table 44. Boston Scientific Corporation Business Overview Table 45. Boston Scientific Corporation Tumor Embolization Product Table 46. Boston Scientific Corporation Revenue in Tumor Embolization Business (2017-2022) & (US$ Million) Table 47. Boston Scientific Corporation Recent Development Table 48. Varian Medical Systems, Inc. Company Detail Table 49. Varian Medical Systems, Inc. Business Overview Table 50. Varian Medical Systems, Inc. Tumor Embolization Product Table 51. Varian Medical Systems, Inc. Revenue in Tumor Embolization Business (2017-2022) & (US$ Million) Table 52. Varian Medical Systems, Inc. Recent Development Table 53. Nordion (Sotera Health) Company Detail Table 54. Nordion (Sotera Health) Business Overview Table 55. Nordion (Sotera Health) Tumor Embolization Product Table 56. Nordion (Sotera Health) Revenue in Tumor Embolization Business (2017-2022) & (US$ Million) Table 57. Nordion (Sotera Health) Recent Development Table 58. Sirtex Medical Company Detail Table 59. Sirtex Medical Business Overview Table 60. Sirtex Medical Tumor Embolization Product Table 61. Sirtex Medical Revenue in Tumor Embolization Business (2017-2022) & (US$ Million) Table 62. Sirtex Medical Recent Development Table 63. Research Programs/Design for This Report Table 64. Key Data Information from Secondary Sources Table 65. Key Data Information from Primary Sources List of Figures Figure 1. Global Tumor Embolization Market Share by Type: 2021 VS 2028 Figure 2. Trans-Arterial Embolization (TAE) Features Figure 3. Drug-Eluting Bead Chemoembolization (DEB-TACE) Features Figure 4. Radioembolization (RE) Features Figure 5. Others Features Figure 6. Global Tumor Embolization Market Share by Application in 2021 & 2028 Figure 7. Hospitals Case Studies Figure 8. Ambulatory Surgical Centers Case Studies Figure 9. Specialty Clinics Case Studies Figure 10. Others Case Studies Figure 11. Tumor Embolization Report Years Considered Figure 12. Global Tumor Embolization Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Tumor Embolization Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Tumor Embolization Market Share by Region: 2021 VS 2028 Figure 15. Global Tumor Embolization Market Share by Players in 2021 Figure 16. Global Top Tumor Embolization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Embolization as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Tumor Embolization Revenue in 2021 Figure 18. North America Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Tumor Embolization Market Share by Country (2017-2028) Figure 20. United States Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Tumor Embolization Market Share by Country (2017-2028) Figure 24. Germany Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Tumor Embolization Market Share by Region (2017-2028) Figure 32. China Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Tumor Embolization Market Share by Country (2017-2028) Figure 40. Mexico Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Tumor Embolization Market Share by Country (2017-2028) Figure 44. Turkey Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Tumor Embolization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Boston Scientific Corporation Revenue Growth Rate in Tumor Embolization Business (2017-2022) Figure 47. Varian Medical Systems, Inc. Revenue Growth Rate in Tumor Embolization Business (2017-2022) Figure 48. Nordion (Sotera Health) Revenue Growth Rate in Tumor Embolization Business (2017-2022) Figure 49. Sirtex Medical Revenue Growth Rate in Tumor Embolization Business (2017-2022) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us